Organization · Venture Capital
Cleveland Life Science Advisors
Cleveland Life Science Advisors (CLSA) is a venture capital firm based in Cleveland, Ohio, focusing on early-stage investments in the life sciences sector. The firm operates the Cleveland Life Sciences Accelerator Fund, targeting transformative healthcare technologies.
Overview
What Cleveland Life Science Advisors does
What Cleveland Life Science Advisors is
Cleveland Life Science Advisors (CLSA) is a venture capital firm based in Cleveland, Ohio, focusing on early-stage investments in the life sciences sector. The firm operates the Cleveland Life Sciences Accelerator Fund, targeting transformative healthcare technologies.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Structured capabilities
- Funder
- Last reviewed
- April 24, 2026
Official channels
Find Cleveland Life Science Advisors elsewhere
Open the official website or a supported primary organization account.
Capability profile
Cleveland Life Science Advisors as a funder
Investment thesis
Cleveland Life Science Advisors focuses on technologies that significantly impact patient care, with a preference for strong intellectual property and exceptional market opportunities.
Focus narrative
CLSA invests in early-stage companies within the life sciences sector, particularly those that can lead to transformative healthcare technologies. Their investment strategy includes a combination of strategic buyouts and initial public offerings (IPOs), typically within a 3-5 year timeframe. The organization seeks innovations that promise both financial returns and humanitarian impact.
Value beyond capital
CLSA adds value to its portfolio companies through strategic guidance, access to a network of industry experts, and partnerships with academic institutions like Case Western Reserve University. The organization emphasizes the importance of strong intellectual property and market potential, providing support to help companies navigate early-stage challenges and achieve growth.
Focus and fit
- Stages
- Pre-seed · Seed · Series A
- Regions
- North AmericaUnited States
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 10
Portfolio context
Notable portfolio companies include: Hemex Health: Developed the Gazelle™ diagnostic platform for blood disorders, achieving significant sales growth and deployment of over 1.2 million tests across 30 countries. Luminary Therapeutics: Focuses on a next-generation CAR-T platform aimed at improving cell therapies for various cancers, with ongoing clinical trials. Prima Medical: Developing an AI-powered platform to enhance catheter ablation procedures for cardiac arrhythmias. Neucore Bio: Works on an engineered exosome platform for gene delivery, addressing limitations of first-generation gene therapies. Tevard Biosciences: Pioneering tRNA therapies to correct genetic disorders caused by nonsense mutations. careMESH: Provides a secure platform for healthcare providers to exchange patient information and coordinate care. Convelo Therapeutics: Developing therapies to regenerate myelin in the central nervous system for conditions like multiple sclerosis. BIOHM: Combines probiotic supplements with microbiome testing to offer personalized gut health recommendations. Vitranu: Focuses on an extended-release delivery platform for therapeutics in ophthalmic conditions. Deep Blue: A medical device company developing innovative solutions in healthcare.
Common questions
What to know about Cleveland Life Science Advisors
Upseed classifies Cleveland Life Science Advisors under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 24, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.